Reneuron Share Chat (RENE)

Find Your Broker

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Reneuron Group	LSE:RENE	London	Ordinary Share	GB00BF5G6K95	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+2.00p	+4.04%	51.50p	51.00p	52.00p	51.50p	49.50p	49.50p	6,889	13:35:35

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-21.0	-55.7	-	16.30

Reneuron Share Discussion Threads

Showing 5901 to 5923 of 5925 messages

Chat Pages: 237 236 235 234 233 232 231 230 229 228 227 226 Older

Date	Subject	Author	Discuss
04/1/2019 13:23	Time to buy, if Waterloo is selling 😜.....	nobbygnome	Read Full Thread Reply
04/1/2019 13:19	Cheers and you.	waterloo01	Read Full Thread Reply
04/1/2019 13:09	Sorry to hear that Waterloo. Hope you have a good 2019 and luck for your other investments.	algernon2	Read Full Thread Reply
04/1/2019 12:46	I'm out. Was hoping the exosome deal would have some cash attached. Looks like it's all been pushed further down the road, again.	waterloo01	Read Full Thread Reply
04/1/2019 12:43	Re Exosome "deal": Some better news at last.Something to build on and hopefully the other Company will follow through unlike the last one that did due diligence on us. happy 2019 folks.	algernon2	Read Full Thread Reply
03/1/2019 18:33	For clarity, rocket fuel posted similar just prior to the 70%+ rally in the shares.. when I was buying. :)	wigwammer	Read Full Thread Reply
03/1/2019 15:35	I don’t think so wiggy.. I posted that just after you bought in at 100p.. ouch! Watch and learn.. drip drip splosh.. zero!	rocket fuel	Read Full Thread Reply
03/1/2019 14:59	Good spot, buywell. Just prior to the 50% rally :)	wigwammer	Read Full Thread Reply
02/1/2019 17:41	Here's to a prosperous 2019 and an exosome deal (amongst several others) to be announced. We deserve a little good news.	algernon2	Read Full Thread Reply
14/12/2018 11:09	Agreed - including 'wish we had their capitalisation'	rotors	Read Full Thread Reply
14/12/2018 10:58	OK the replay works for me. Maybe it was a problem that I joined late. Interesting comments on SanBio above.	charlie	Read Full Thread Reply
14/12/2018 10:10	Works for me	rotors	Read Full Thread Reply
14/12/2018 09:53	Is anyone on the webcast? It keeps cutting out for me after about 3 mins of listening.	charlie	Read Full Thread Reply
14/12/2018 09:35	Reassuring	bonzo	Read Full Thread Reply
07/11/2018 21:24	Pisces iii trial just changed status from 'not yet recruiting' to 'recruiting' hTTps://clinicaltrials.gov/ct2/results?cond=&term=&type=&rslt=&age_v=&gndr=&intr=&titles=&outc=&spons=Reneuron&lead=&;id=&cntry=&state=&city=&;dist=&locn=&;strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&;sfpd_e=&lupd_s=&lupd_e=&sort=	philh75	Read Full Thread Reply
06/11/2018 10:42	I think perceptions can change quickly, even on AIM. My point really relates to RENE's ability to out-license CTX which I believe is gapping up behind the scenes. SanBio uses an allogeneic technology similar to that used by RENE, they have demonstrated it works in a blinded randomised trial. The value the market is placing on such assets is demonstrably rising in the background. Having read around the history of the company and the IP that RENE have developed, I have little doubt they are in the top tier in this field. Note also that SanBio are applying for conditional marketing approval in Japan, which is possible for companies after a successful phase II given the governments drive to dominate the field of regenerative medicine - the route to market is significantly shorter. Therefore RENE's assets may be particularly interesting to any company capable of engaging the Japanese market - there are many of them :)	wigwammer	Read Full Thread Reply
06/11/2018 10:25	I think someone else did that Al.	small crow	Read Full Thread Reply
06/11/2018 10:04	SanBio has now nearly doubled in a week. £2bn market cap. Comparable pipeline to RENE. RENE market cap £20m. Potential here is huge :)	wigwammer	Read Full Thread Reply
04/11/2018 16:13	It looks like interest in regenerative medicine and it's potential in brain injury is about to take a step up. See attachment below. This is very good news for Reneuron IMO as they aim to partner the CTX line, and explains the slightly firmer share price in recent days. Market cap of SanBio is now £1.5bn, jumping 20% since the result. Market cap of Reneuron with comparable pipeline technology is £20m. http://v4.eir-parts.net/DocumentTemp/20181105_010629011_n2un4tv5ffyvhi55pzhsiy55_0.pdf	wigwammer	Read Full Thread Reply
01/11/2018 14:27	Interesting day.	small crow	Read Full Thread Reply
22/10/2018 07:45	hTtps://uk.advfn.com/stock-market/london/hemogenyx-HEMO/share-news/Hemogenyx-Pharmaceuticals-PLC-Orgenesis-collaborat/78504535	badger60	Read Full Thread Reply
21/10/2018 20:22	" Breakthrough to open up potential new revenue opportunities for Reneuron Plc " not yet posted from October 18th. hTTps://www.youtube.com/watch?v=bDRp7AnkU9E	algernon2	Read Full Thread Reply
19/10/2018 09:59	More encouraging news and look where the share price still is... :-( lots of brass lost here!!	stewart_25	Read Full Thread Reply

Chat Pages: 237 236 235 234 233 232 231 230 229 228 227 226 Older